Gastric Bicarbonate Secretion and Release of Prostaglandin E₂ Are Increased in Duodenal Ulcer Patients But Not in Helicobacter pylori-Positive Healthy Subjects

References

• Misiewicz JJ. Helicobacter pylori: past, present, and future. Scand J Gastroenterol 1992; 27: 25–9, Suppl 194
   PubMed Web of Science ®Google Scholar
• Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993; 328: 349–50
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J. New targets for anti-ulcer therapy. Eur J Gastroenterol Hepatol 1993; 5: 493–4
   Google Scholar
• Lamers CBHW. Gastric secretory abnormalities in duodenal ulcer: primary or secondary to Helicobacter pylori infection. Scand J Gastroenterol 1992; 27: 99–103, Suppl 194
   PubMed Web of Science ®Google Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–7
   PubMed Web of Science ®Google Scholar
• Isenberg JI, Flemström G. Physiology and pathophysiology of gastroduodenal bicarbonate secretion. Viewpoints Dig Dis 1991; 23: 27–33
   Google Scholar
• Starlinger M. Role of alkaline secretion and cell restitution in duodenal mucosal protection. J Intern Med 1990; 228: 109–12, Suppl 732
   Google Scholar
• Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment. Gastroenterology 1985; 89: 1162–88
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Lauritsen K. Enhancement of mucosal defence by prostaglandins. Rationale and clinical experience in ulcer disease. Scand J Gastroenterol 1987; 22: 34–42, Suppl 128
   Web of Science ®Google Scholar
• Bukhave K, Rask-Madsen J, Hogan DL, Koss MA, Isenberg JI. Proximal duodenal prostaglandin E2 release and mucosal bicarbonate secretion are altered in patients with duodenal ulcer. Gastroenterology 1990; 99: 951–5
   PubMedGoogle Scholar
• Sharon P, Cohen F, Zifroni A, Karmeli F, Ligumsky M, Rachmilewitz D. Prostaniod synthesis by cultured gastric and duodenal mucosa: possible role in the pathogenesis of duodenal ulcer. Scand J Gastroenterol 1983; 18: 1045–9
   PubMed Web of Science ®Google Scholar
• Hillier K, Smith CL, Jewell R, Arthur MJP, Ross G. Duodenal mucosa synthesis of prostaglandins in duodenal disease. Gut 1985; 26: 237–40
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Obtulowicz W, Sito E, Oleksy J, Wilkon S, Dembinska-Kiec A. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients. Gut 1981; 22: 283–9
   PubMed Web of Science ®Google Scholar
• Crampton JR, Gibbons LC, Rees WDW. Simultaneous measurement of in vitro gastroduodenal prostaglandin E2 synthesis and degradation in peptic disease. Scand J Gastroenterol 1987; 22: 425–30
   PubMed Web of Science ®Google Scholar
• Cryer B, Faust TW, Goldschmiedt M, Redfern JS, Lee E, Feldman M. Gastric and duodenal mucosal prostaglandin concentrations in gastric or duodenal ulcer disease: relationships with demographics, environmental, and histological factors, including Helicobacter pylori. Am J Gastroenterol 1992; 87: 1747–54
   PubMed Web of Science ®Google Scholar
• Ahlquist DA, Dozois RR, Zinsmeister AR, Malagelada J-R. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology 1983; 85: 522–8
   PubMed Web of Science ®Google Scholar
• Aly A, Johansson C, Slezak P, Grèen K. Bioconversion of arachidonic acid in the human gastrointestinal tract. Biochem Med 1984; 31: 319–31
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Kwiecien N, Obtulowicz W, Thor P, Konturek JW, Popiela T. Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients. Gut 1987; 28: 739–44
   PubMed Web of Science ®Google Scholar
• Cheung LY, Jubiz W, Moore JG. Gastric prostaglandin E output during basal and stimulated acid secretion in healthy controls and patients with duodenal ulcer. J Surg Res 1976; 20: 369–72
   PubMed Web of Science ®Google Scholar
• Befrits R, Aly A, Musat A, Gréen K, Johansson C. Autoregulation of gastric acid secretion in healthy subjects and duodenal ulcer; possible relation to local prostaglandin E2 formation. Eur J Gastroenterol Hepatol 1991; 3: 763–8
   Google Scholar
• Malagelada JR. Prostaglandin metabolism in peptic ulcer disease. Scand J Gastroenterol 1986; 21: 136–41, Suppl 125
   Web of Science ®Google Scholar
• Stange EF, Preclik G, Ditschuneit H. Prostaglandin biosynthesis in gastroduodenal mucosa: methodological difficulties and their implications. Scand J Gastroenterol 1986; 21: 121–5, Suppl 125
   Web of Science ®Google Scholar
• Isenberg JI, Selling JA, Hogan DL, Koss MA. Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer. N Engl J Med 1987; 316: 374–9
   PubMed Web of Science ®Google Scholar
• Mertz-Nielsen A, Hillingsø J, Eskerod O, Bukhave K, Rask-Madsen J. Muscarinic M1-receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes gastric prostaglandin E2 synthesis in healthy volunteers. Gut 1994; 36: 528–33
   Google Scholar
• Mertz-Nielsen A, Munck LK, Bukhave K, Rask-Madsen J. Muscarinic M1 receptors regulate gastric mucosal prostaglandin E2 formation. Eur J Gastroenterol Hepatol 1989; 1: 57–62
   Google Scholar
• Knutson L, Flemström G. Duodenal mucosal bicarbonate secretion in man. Stimulation by acid and inhibition by the alpha2-adrenoceptor agonist clonidine. Gut 1989; 30: 1708–15
   PubMed Web of Science ®Google Scholar
• Odes HS, Hogan DL, Steinbach JH, Ballesteros MA, Koss MA, Isenberg JI. Measurement of gastric bicarbonate secretion in the human stomach: different methods produce discordant results. Scand J Gastroenterol 1992; 27: 829–36
   PubMed Web of Science ®Google Scholar
• Bukhave K, Gréen K, Rask-Madsen J. Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2α in gastrointestinal fluids. Biomed Mass Spectrom 1983; 10: 265–8
   PubMedGoogle Scholar
• Andersen LP, Raskov H, Elsborg L, Holck S, Justesen T, Fischer-Hansen B. Prevalence of antibodies against heatstable antigens from Helicobacter pylori. in patients with dyspeptic symptoms and normal persons. APMIS 1992; 100: 779–89
   PubMed Web of Science ®Google Scholar
• Andersen LP, Espesen F. Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol 1992; 30: 1743–51
   PubMed Web of Science ®Google Scholar
• DiMagno EP. Alterations and consequences of interdigestive and poststimulatory human exocrine pancreatic secretion in health and disease. Basic science in gastroenterology. Physiology of the gut., JM Polak, SR Bloom, NA Wright, AG Butler. Glaxo Group Research Ltd., Ware, Herts 1984; 251–66
   Google Scholar
• Feldman M, Barnett CC. Gastric bicarbonate secretion in patients with duodenal ulcer. Gastroenterology 1985; 88: 1205–8
   PubMedGoogle Scholar
• Forssell H, Olbe L. Effect of proximal gastric vagotomy on basal and vagally stimulated gastric bicarbonate secretion in duodenal ulcer patients. Scand J Gastroenterol 1987; 22: 949–55
   PubMed Web of Science ®Google Scholar
• Rapier RC, Dreilinger AD, Nyberg LM, Koss MA, Hogan DL, Isenberg JI. Helicobacter pylori diminishes proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer disease. Gastroenterology 1994; 106: A164
   Google Scholar
• Hamlet A, Dalenbäck J, Olbe L, Fändriks L. Does antral distension inhibit gastric acid secretion or stimulate bicarbonate secretion in ‘healthy’ subjects. Scand J Gastroenterol 1993; 28: 999–1004
   PubMed Web of Science ®Google Scholar
• Rapier RC, Hogan DL, Koss MA, Isenberg JI. The effect of age on human duodenal mucosal bicarbonate secretion [abstract]. Gastroenterology 1993; 104: A2406
   Google Scholar
• Selling JA, Hogan DL, Aly A, Koss MA, Isenberg JI. Indomethacin inhibits duodenal mucosal bicarbonate secretion and endogenous prostaglandin E2 output in human subjects. Ann Intern Med 1987; 106: 368–71
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Bukhave K. The difficulties of establishing the pathophysiological role of prostaglandins in secretion. Intestinal absorption and secretion, E Skadhauge, K Heintze. MTP Press, Lancaster 1984; 453–68
   Google Scholar
• Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol 1993; 24: 577–83
   PubMed Web of Science ®Google Scholar
• Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steriodal anti-inflammatory drugs. Gut 1993; 34: 748–51
   PubMed Web of Science ®Google Scholar
• Taha AS, Boothman P, Holland P, McKinlay A, Upadhyay R, Kelly RW. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am J Gastroenterol 1990; 85: 47–50
   PubMed Web of Science ®Google Scholar
• Avunduk C, Suliman M, Gang D, Polakowski N, Eastwood GL. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate. Dig Dis Sci 1991; 36: 431–4
   PubMed Web of Science ®Google Scholar